Temporal Trends in Pacemaker Implantations Over the Past Decade in France: Impact of Transcatheter Aortic Valve Implantations

Vasileios Sousonis; Roberto Menè; Sophie Jacob; Sarah Zeriouh; Jérôme van Rothem; Eloi Marijon; Stéphane Combes; Serge Boveda

doi:10.1016/j.amjcard.2023.07.075

Temporal Trends in Pacemaker Implantations Over the Past Decade in France: Impact of Transcatheter Aortic Valve Implantations

Am J Cardiol. 2023 Sep 15:203:403-405. doi: 10.1016/j.amjcard.2023.07.075. Epub 2023 Jul 29.

Authors

Vasileios Sousonis¹, Roberto Menè², Sophie Jacob³, Sarah Zeriouh¹, Jérôme van Rothem⁴, Eloi Marijon⁵, Stéphane Combes¹, Serge Boveda⁶

Affiliations

¹ Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.
² Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
³ Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Laboratory of Epidemiology, Fontenay-aux-Roses, France.
⁴ Cardiology Department, Clinique Pasteur, Toulouse, France.
⁵ Paris Cardiovascular Research Center, INSERM U970, Paris, France; Cardiology Department, European Georges Pompidou Hospital, Paris, France.
⁶ Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France; Heart Rhythm Management Centre, Universitair Ziekenhuis Brussel-VUB, Brussels, Belgium. Electronic address: [email protected].

PMID: 37523936
DOI: 10.1016/j.amjcard.2023.07.075

Abstract

In this study, we assessed the temporal trends of permanent pacemaker implantations in France from 2008 to 2018 using data from the Échantillon Généraliste de Bénéficiaires (EGB) administrative database, a representative sample of the French population. Additionally, we evaluated the impact of transcatheter aortic valve implantations on the overall pacemaker implantation rate. Our data suggest that the incidence of permanent pacemaker implantations in France increased significantly only in patients ≥80 years old, with post-transcatheter aortic valve implantations accounting for at least 2/3 of this increase.

Keywords: France; TAVI; aging; conduction disease; pacemaker implantation.

MeSH terms

Aged, 80 and over
Aortic Valve / surgery
Aortic Valve Stenosis* / epidemiology
Aortic Valve Stenosis* / surgery
France / epidemiology
Heart Valve Prosthesis*
Humans
Pacemaker, Artificial*
Risk Factors
Transcatheter Aortic Valve Replacement*
Treatment Outcome